Amidst increased PE involvement in sports and rapidly rising team valuations, the Giants and 49ers owners seek minority stake sales.

Novartis reacquires Anthos from Blackstone after cardiovascular drug abelacimab shows promise. A successful PE/Biopharma model emerges.